These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 18456336)

  • 1. Dynamic structural changes during complement C3 activation analyzed by hydrogen/deuterium exchange mass spectrometry.
    Schuster MC; Ricklin D; Papp K; Molnar KS; Coales SJ; Hamuro Y; Sfyroera G; Chen H; Winters MS; Lambris JD
    Mol Immunol; 2008 Jun; 45(11):3142-51. PubMed ID: 18456336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural insights on complement activation.
    Alcorlo M; López-Perrote A; Delgado S; Yébenes H; Subías M; Rodríguez-Gallego C; Rodríguez de Córdoba S; Llorca O
    FEBS J; 2015 Oct; 282(20):3883-91. PubMed ID: 26250513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solvent accessibility of native and hydrolyzed human complement protein 3 analyzed by hydrogen/deuterium exchange and mass spectrometry.
    Winters MS; Spellman DS; Lambris JD
    J Immunol; 2005 Mar; 174(6):3469-74. PubMed ID: 15749882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Self-association and domain rearrangements between complement C3 and C3u provide insight into the activation mechanism of C3.
    Li K; Gor J; Perkins SJ
    Biochem J; 2010 Oct; 431(1):63-72. PubMed ID: 20666732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The structure of complement C3b provides insights into complement activation and regulation.
    Abdul Ajees A; Gunasekaran K; Volanakis JE; Narayana SV; Kotwal GJ; Murthy HM
    Nature; 2006 Nov; 444(7116):221-5. PubMed ID: 17051152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3D structure of the C3bB complex provides insights into the activation and regulation of the complement alternative pathway convertase.
    Torreira E; Tortajada A; Montes T; Rodríguez de Córdoba S; Llorca O
    Proc Natl Acad Sci U S A; 2009 Jan; 106(3):882-7. PubMed ID: 19136636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure of Complement C3(H2O) Revealed By Quantitative Cross-Linking/Mass Spectrometry And Modeling.
    Chen ZA; Pellarin R; Fischer L; Sali A; Nilges M; Barlow PN; Rappsilber J
    Mol Cell Proteomics; 2016 Aug; 15(8):2730-43. PubMed ID: 27250206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of the C3b binding site in a recombinant vWF-A domain of complement factor B by surface-enhanced laser desorption-ionisation affinity mass spectrometry and homology modelling: implications for the activity of factor B.
    Hinshelwood J; Spencer DI; Edwards YJ; Perkins SJ
    J Mol Biol; 1999 Nov; 294(2):587-99. PubMed ID: 10610782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tyrosine is a potential site for covalent attachment of activated complement component C3.
    Sahu A; Pangburn MK
    Mol Immunol; 1995 Jul; 32(10):711-6. PubMed ID: 7659097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Solution insights into the structure of the Efb/C3 complement inhibitory complex as revealed by lysine acetylation and mass spectrometry.
    Chen H; Schuster MC; Sfyroera G; Geisbrecht BV; Lambris JD
    J Am Soc Mass Spectrom; 2008 Jan; 19(1):55-65. PubMed ID: 18293486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure of C3b reveals conformational changes that underlie complement activity.
    Janssen BJ; Christodoulidou A; McCarthy A; Lambris JD; Gros P
    Nature; 2006 Nov; 444(7116):213-6. PubMed ID: 17051160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural Implications for the Formation and Function of the Complement Effector Protein iC3b.
    Papanastasiou M; Koutsogiannaki S; Sarigiannis Y; Geisbrecht BV; Ricklin D; Lambris JD
    J Immunol; 2017 Apr; 198(8):3326-3335. PubMed ID: 28258193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural insights into the central complement component C3.
    Janssen BJ; Gros P
    Mol Immunol; 2007 Jan; 44(1-3):3-10. PubMed ID: 16875735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Component C3 of hagfish complement has a unique structure: identification of native C3 and its degradation products.
    Fujii T; Nakamura T; Tomonaga S
    Mol Immunol; 1995 Jun; 32(9):633-42. PubMed ID: 7643855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hybrid proteins of Cobra Venom Factor and cobra C3: tools to identify functionally important regions in Cobra Venom Factor.
    Hew BE; Wehrhahn D; Fritzinger DC; Vogel CW
    Toxicon; 2012 Sep; 60(4):632-47. PubMed ID: 22609532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complement component C3: A structural perspective and potential therapeutic implications.
    Geisbrecht BV; Lambris JD; Gros P
    Semin Immunol; 2022 Jan; 59():101627. PubMed ID: 35760703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A revised mechanism for the activation of complement C3 to C3b: a molecular explanation of a disease-associated polymorphism.
    Rodriguez E; Nan R; Li K; Gor J; Perkins SJ
    J Biol Chem; 2015 Jan; 290(4):2334-50. PubMed ID: 25488663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of C3 in C3 glomerulopathy.
    Sethi S; Vrana JA; Fervenza FC; Theis JD; Sethi A; Kurtin PJ; Zhang Y; Smith RJH
    Nephrol Dial Transplant; 2017 Mar; 32(3):459-465. PubMed ID: 27507892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physiologic inactivation of fluid phase C3b: isolation and structural analysis of C3c, C3d,g (alpha 2D), and C3g.
    Davis AE; Harrison RA; Lachmann PJ
    J Immunol; 1984 Apr; 132(4):1960-6. PubMed ID: 6607952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of human complement by a C3-binding peptide isolated from a phage-displayed random peptide library.
    Sahu A; Kay BK; Lambris JD
    J Immunol; 1996 Jul; 157(2):884-91. PubMed ID: 8752942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.